Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 42 min ago
Peer-reviewedCC BY-NC-NDMolecular therapy. Nucleic acids

Anti-PD-L1 scFv-secreting fifth-generation GD2-CAR T cells enhance antitumor function against GD2-low retinoblastoma

  • Pornpimon Yuti1
  • Katesara Kongkla1
  • Nunghathai Sawasdee1
  • Yupanun Wutti-in2
  • Nattaporn Phanthaphol1
  • Naravat Poungvarin3
  • Mutita Junking1
  • Pa-thai Yenchitsomanus1
  • Jatuporn Sujjitjoon1
  1. 1Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Division of Molecular Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
  2. 2Division of Transfusion Sciences, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
  3. 3Department of Clinical Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
Read full textPDFCite

Related

  1. Reframing enzyme function prediction as conditional generation
    W. J. Rieger, S. Haeussermann, L. Herrmann +9
    bioRxivPreprintCC BYFull textMolecular biology & gene regulationbioRxiv
  2. Patterning human kidney organoids with synthetic Wnt-secreting organizers
    Connor C. Fausto, Fokion Glykofrydis, Navneet Kumar +15
    SciencePeer-reviewedCC BY12 citedMolecular biology & gene regulationOncologyOpenAlex
  3. m6A-modified mRNA–LNP system enables in vivo CAR expression and is associated with antitumor immune responses
    Sikun Meng, Tomoaki Hara, Tetsuya Sato +14
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationCrossref
  4. 1068 Innate and adaptive immune responses and antitumor activity associated with ARV-6723, a PROTAC HPK1 degrader, in exhausted/post-immune checkpoint inhibitor (ICI) preclinical settings
    Wendy Wu, Rebecca Conrad, Morena Scopel +13
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textMolecular biology & gene regulationDOAJ
  5. A Targeted Liposomal Delivery System for Hydrophobic Antitumor Compounds Using the Example of a 1,2,3,4-Tetrahydroisoquinoline Derivative.
    G M Proshkina, O N Ashirov, M N Zharkov +8
    Acta naturaePeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{yuti2026antipdl1,
  title = {{Anti-PD-L1 scFv-secreting fifth-generation GD2-CAR T cells enhance antitumor function against GD2-low retinoblastoma}},
  author = {Pornpimon Yuti and Katesara Kongkla and Nunghathai Sawasdee and Yupanun Wutti-in and Nattaporn Phanthaphol and Naravat Poungvarin and Mutita Junking and Pa-thai Yenchitsomanus and Jatuporn Sujjitjoon},
  journal = {Molecular therapy. Nucleic acids},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13671088},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Anti-PD-L1 scFv-secreting fifth-generation GD2-CAR T cells enhance antitumor function against GD2-low retinoblastoma
AU  - Pornpimon Yuti
AU  - Katesara Kongkla
AU  - Nunghathai Sawasdee
AU  - Yupanun Wutti-in
AU  - Nattaporn Phanthaphol
AU  - Naravat Poungvarin
AU  - Mutita Junking
AU  - Pa-thai Yenchitsomanus
AU  - Jatuporn Sujjitjoon
PY  - 2026
DA  - 2026/09/24
JO  - Molecular therapy. Nucleic acids
UR  - https://europepmc.org/article/PMC/PMC13671088
SN  - 2162-2531
ER  -